Drug Profile
Research programme: hCG monoclonal antibodies - CG Therapeutics/University of Washington
Latest Information Update: 29 Jun 2015
Price :
$50
*
At a glance
- Originator CG Therapeutics; University of Washington
- Class Monoclonal antibodies
- Mechanism of Action Gonadotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 29 Jun 2015 Discontinued - Preclinical for Cancer in USA (Parenteral)
- 04 Apr 2008 Preclinical trials in Cancer in USA (Parenteral)